Wrapmanager Inc Gilead Sciences, Inc. Transaction History

Wrapmanager Inc

$382 Million
Q3 2024

A detailed history of Wrapmanager Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wrapmanager Inc holds 9,917 shares of GILD stock, worth $905,917. This represents 0.22% of its overall portfolio holdings.

Number of Shares

9,917

Previous 11,448 13.37%

Holding current value

$905,917

Previous $785,000 5.86%

% of portfolio

0.22%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$66.59 - $83.99 $101,949 - $128,588	-1,531 Reduced 13.37%	9,917 $831,000
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $27,470 - $31,702	-435 Reduced 3.66%	11,448 $785,000
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $82,674 - $100,819	1,155 Added 10.77%	11,883 $870,000
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $30,846 - $34,980	421 Added 4.08%	10,728 $869,000
Q3 2023 Nov 06, 2023	SELL	$73.94 - $80.67 $13,531 - $14,762	-183 Reduced 1.74%	10,307 $772,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $300,771 - $343,071	-3,957 Reduced 27.39%	10,490 $808,000
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $767,069 - $873,929	-9,922 Reduced 40.72%	14,447 $1.2 Million
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $66,557 - $95,553	1,068 Added 4.58%	24,369 $2.09 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $26,495 - $30,264	445 Added 1.95%	23,301 $1.44 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $99,740 - $112,337	1,728 Added 8.18%	22,856 $1.41 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $142,599 - $178,691	2,462 Added 13.19%	21,128 $1.26 Million
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $27,054 - $30,707	417 Added 2.29%	18,666 $1.36 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $19,088 - $20,594	-282 Reduced 1.52%	18,249 $1.28 Million
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $178,794 - $195,358	2,817 Added 17.93%	18,531 $1.28 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $139,440 - $159,101	2,324 Added 17.36%	15,714 $1.02 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $101,573 - $115,738	-1,793 Reduced 11.81%	13,390 $780,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $441,034 - $554,524	7,102 Added 87.89%	15,183 $959,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $894,918 - $1.04 Million	-12,371 Reduced 60.49%	8,081 $622,000
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $156,700 - $200,710	2,502 Added 13.94%	20,452 $1.53 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $109,005 - $119,902	-1,769 Reduced 8.97%	17,950 $1.17 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.23 Million - $1.36 Million	19,719 New	19,719 $1.25 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.

Account